Home

Ţipăt amăgire mai mult și mai mult biochemical markers in liver disease carol davila legătură Mary sac

Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease and  Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and  Therapeutic Management | HTML
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management | HTML

Cureus | Correlation Between Serum Alpha-Fetoprotein and Tumour Size in  Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals
Cureus | Correlation Between Serum Alpha-Fetoprotein and Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals

PDF) The non-invasive assessment of hepatic fibrosis
PDF) The non-invasive assessment of hepatic fibrosis

Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease and  Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and  Therapeutic Management | HTML
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management | HTML

Healthcare | Free Full-Text | State of the Art in Hepatic Dysfunction in  Pregnancy | HTML
Healthcare | Free Full-Text | State of the Art in Hepatic Dysfunction in Pregnancy | HTML

Medicina | Free Full-Text | Electrocardiographic Changes in Liver Cirrhosis—Clues  for Cirrhotic Cardiomyopathy | HTML
Medicina | Free Full-Text | Electrocardiographic Changes in Liver Cirrhosis—Clues for Cirrhotic Cardiomyopathy | HTML

Differential diagnosis between occupational chronic intoxication with  organic solvents and ethanol abuse by biological markers.
Differential diagnosis between occupational chronic intoxication with organic solvents and ethanol abuse by biological markers.

PDF) Non – biopsy methods to determine hepatic fibrosis
PDF) Non – biopsy methods to determine hepatic fibrosis

University of Medicine and Pharmacy “Carol Davila”, Bucharest - ppt download
University of Medicine and Pharmacy “Carol Davila”, Bucharest - ppt download

University of Medicine and Pharmacy “Carol Davila”, Bucharest - ppt download
University of Medicine and Pharmacy “Carol Davila”, Bucharest - ppt download

PDF) Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities:  Pathophysiological Links, Diagnosis, and Therapeutic Management
PDF) Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management

University of Medicine and Pharmacy “Carol Davila”, Bucharest - ppt download
University of Medicine and Pharmacy “Carol Davila”, Bucharest - ppt download

PDF) Liver Involvement in Patients with Systemic Autoimmune Diseases
PDF) Liver Involvement in Patients with Systemic Autoimmune Diseases

Frontiers | Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a  Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by  the Hepatokine/Adipokine Axis Breakdown
Frontiers | Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown

PDF) Biochemical markers in vascular cognitive impairment associated with  subcortical small vessel disease - A consensus report
PDF) Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

Cardiovascular risk assessment in osteoporotic patients using  osteoprotegerin as a reliable predictive biochemical marker
Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker

PDF) Acute Fatty Liver of Pregnancy
PDF) Acute Fatty Liver of Pregnancy

JCM | Free Full-Text | An Overview on Primary Sclerosing Cholangitis | HTML
JCM | Free Full-Text | An Overview on Primary Sclerosing Cholangitis | HTML

From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver  disease
From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease

Dipeptidyl peptidase-3 is associated with severity of liver disease and  circulatory complications in patients with cirrhosis: Biomarkers: Vol 27,  No 2
Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis: Biomarkers: Vol 27, No 2

Cureus | Correlation Between Serum Alpha-Fetoprotein and Tumour Size in  Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals
Cureus | Correlation Between Serum Alpha-Fetoprotein and Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals

PDF) Serum Iron Markers in Patients With Chronic Hepatitis C Infection
PDF) Serum Iron Markers in Patients With Chronic Hepatitis C Infection

PDF) Association between Liver Cirrhosis and Diabetes Mellitus: A Review on  Hepatic Outcomes
PDF) Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes

Diagnostics | Free Full-Text | Clinical Model for the Prediction of Severe  Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus | HTML
Diagnostics | Free Full-Text | Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus | HTML

Cureus | Correlation Between Serum Alpha-Fetoprotein and Tumour Size in  Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals
Cureus | Correlation Between Serum Alpha-Fetoprotein and Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals

Oral Presentations - 2014 - Hepatology - Wiley Online Library
Oral Presentations - 2014 - Hepatology - Wiley Online Library

PDF) Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients  with Nonalcoholic Fatty Liver Disease (NAFLD) | Cristian Baicus -  Academia.edu
PDF) Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) | Cristian Baicus - Academia.edu